Aytu Biopharma (AYTU) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Aytu Biopharma (AYTU) over the last 4 years, with Sep 2025 value amounting to -$0.08.
- Aytu Biopharma's EPS (Weighted Average and Diluted) rose 60.00% to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.35, marking a year-over-year increase of 83.25%. This contributed to the annual value of -$5.11 for FY2023, which is 93.10% up from last year.
- Latest data reveals that Aytu Biopharma reported EPS (Weighted Average and Diluted) of -$0.08 as of Q3 2025, which was down 138.10% from $0.21 recorded in Q1 2025.
- Aytu Biopharma's 5-year EPS (Weighted Average and Diluted) high stood at $0.21 for Q1 2025, and its period low was -$35.90 during Q1 2022.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.28 (2024), whereas its average is -$0.51.
- Per our database at Business Quant, Aytu Biopharma's EPS (Weighted Average and Diluted) slumped by 6,117.14% in 2021 and then spiked by 140.38% in 2025.
- Aytu Biopharma's EPS (Weighted Average and Diluted) (Quarterly) stood at -$8.74 in 2021, then skyrocketed by 75.40% to -$2.15 in 2022, then spiked by 105.12% to $0.11 in 2023, then tumbled by 354.55% to -$0.28 in 2024, then soared by 60.00% to -$0.08 in 2025.
- Its last three reported values are -$0.08 in Q3 2025, $0.21 for Q1 2025, and -$0.28 during Q4 2024.